Equivalence Between Oral and Intravenous Antibiotics When Treating Serious Staphylococcal Infections?
نویسندگان
چکیده
منابع مشابه
Comparing the use of intravenous antibiotics under the medical benefit with the use of oral antibiotics under the pharmacy benefit in treating skin and soft tissue infections.
PURPOSE To assess differences in the simultaneous management of pharmacy and medical benefits by analyzing the health care utilization and costs associated with managed care patients who received oral linezolid as a pharmacy benefit or intravenous (IV) daptomycin or IV vancomycin as medical benefits for skin and soft tissue infections (SSTIs). METHODOLOGY The first medical or pharmacy claim f...
متن کاملSequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
The efficacy and safety of sequential intravenous/oral ciprofloxacin in moderate to severe respiratory tract infections (RTI) were compared with those of ceftazidime in a prospective clinical trial. Sixty-six patients received IV ciprofloxacin (200 to 300 mg twice daily), followed by oral ciprofloxacin (500 mg twice daily). Fifty-six patients received intravenous ceftazidime (1 to 2 g two to th...
متن کاملInhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections.
Pantothenate kinase (CoaA) catalyzes the first step of the coenzyme A biosynthetic pathway. Here we report the identification of the Staphylococcus aureus coaA gene and characterization of the enzyme. We have also identified a series of low-molecular-weight compounds which are effective inhibitors of S. aureus CoaA.
متن کاملIntravenous use of cephradine and cefazolin against serious infections.
The relative efficacy and safety of cephradine and cefazolin were compared in 180 patients with a variety of serious infections caused by susceptible organisms. The patients were randomly assigned to one of two groups of 90 patients each. Most patients received 2 to 4 g per day, administered by intravenous injection in four equally divided doses, for a minimum of 4 days. Based on the clinical a...
متن کاملBeyond antibiotics: new horizons in treating burkholderia species infections.
Antibiotic-resistant strains of pathogenic bacteria have always been an issue, but in recent times the need for new antimicro-bial treatments has never been more serious. Resistance is on the rise, while antibiotic discovery and development are on the decline [1]. The urge for new treatment modalities that go beyond antibiotics is clearly illustrated in the care of patients with chronic granulo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2005
ISSN: 1058-4838,1537-6591
DOI: 10.1086/427951